secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001999371-25-007625
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix enters $150M ATM equity facility and $75M Lincoln Park purchase agreement
-------------------------------------------------------------------------------

- ATM facility with A.G.P. allows sale of up to $150M in common stock at 3% commission.
- Lincoln Park Purchase Agreement enables up to $75M in stock sales with 97% of VWAP pricing.
- Issued 48,708 commitment shares to Lincoln Park as fee; no upper price limit for purchases.
- Lincoln Park purchases capped at 1,470,703 shares (19.99% of outstanding) unless stockholder approval or price ≥$37.74.
- Proceeds expected for working capital and general corporate purposes; existing shelf registration utilized.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125007625/0001999371-25-007625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125007625/tnxp-8k.htm
  HTML page:      https://secwatch.observer/filing/0001999371-25-007625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer